✦ LIBER ✦

A marker for type I collagen degradation identified in urine from patients with Paget’s disease of bone

✍ Scribed by S.M Krane

Book ID: 117808839
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 20 KB
Volume: 24
Category: Article
ISSN: 8756-3282
DOI: 10.1016/s8756-3282(99)00054-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary crosslinked N-telopeptide of typ

Urinary crosslinked N-telopeptide of type I collagen and crosslaps as markers of bone resorption in patients with Paget’s disease of bone

✍ S.J. Iqbal; P. Whittaker; T. Davies 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Serum markers of type I collagen formati

Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry

✍ Erik F. Eriksen; Peder Charles; Flemming Melsen; Leif Mosekilde; Leila Risteli; 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 523 KB

The bisphosphonate zoledronate decreases

The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget’s disease of bone

✍ P Garnero; S Christgau; P.D Delmas 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Circulating type I collagen degradation

Circulating type I collagen degradation products: a new serum marker for clinical severity in patients with scleroderma?

✍ Hunzelmann; Risteli; Risteli; Sacher; Vancheeswaran; Black; Krieg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Systemic sclerosis (SSc; scleroderma) results in the excessive deposition of extracellular matrix components in affected organs. This is partly due to enhanced synthesis; however, the role of degradative processes in this disease is still poorly understood. Sera of 32 patients with SSc (22 with the

Increased cartilage type II collagen deg

Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations

✍ Jean-Charles Rousseau; Guillaume Chevrel; Anne-Marie Schott; Patrick Garnero 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Serum concentration of type I collagen m

Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma

✍ Ken-ichiro Yoshida; Shuhei Sumi; Kyoko Arai; Fumitaka Koga; Hiroshi Umeda; Yoshi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Background: Bone scans, widely used for the detection of bone metastases from prostate carcinoma, can neither quantitate metastatic lesions nor detect osteolytic lesions. ## Methods: Serum concentrations of the carboxyterminal propeptide of type i procollagen (picp), the carboxyterminal pyridi